Bank of New Hampshire’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6K | Sell |
140
-80
| -36% | -$6.63K | ﹤0.01% | 393 |
|
|
2025
Q1 | $17.8K | Sell |
220
-115
| -34% | -$9.33K | ﹤0.01% | 359 |
|
|
2024
Q4 | $30.2K | Hold |
335
| – | – | 0.01% | 322 |
|
|
2024
Q3 | $33.1K | Sell |
335
-220
| -40% | -$21.7K | 0.01% | 321 |
|
|
2024
Q2 | $51.5K | Sell |
555
-135
| -20% | -$12.5K | 0.01% | 313 |
|
|
2024
Q1 | $65.5K | Sell |
690
-233
| -25% | -$22.1K | 0.02% | 291 |
|
|
2023
Q4 | $82.4K | Sell |
923
-647
| -41% | -$57.8K | 0.02% | 270 |
|
|
2023
Q3 | $115K | Sell |
1,570
-161
| -9% | -$11.8K | 0.03% | 238 |
|
|
2023
Q2 | $144K | Sell |
1,731
-205
| -11% | -$17.1K | 0.04% | 216 |
|
|
2023
Q1 | $148K | Sell |
1,936
-60
| -3% | -$4.57K | 0.04% | 209 |
|
|
2022
Q4 | $166K | Sell |
1,996
-210
| -10% | -$17.5K | 0.05% | 198 |
|
|
2022
Q3 | $175K | Sell |
2,206
-180
| -8% | -$14.3K | 0.05% | 195 |
|
|
2022
Q2 | $177K | Sell |
2,386
-1,639
| -41% | -$122K | 0.05% | 200 |
|
|
2022
Q1 | $362K | Sell |
4,025
-965
| -19% | -$86.8K | 0.09% | 161 |
|
|
2021
Q4 | $559K | Sell |
4,990
-1,581
| -24% | -$177K | 0.14% | 139 |
|
|
2021
Q3 | $890K | Hold |
6,571
| – | – | 0.24% | 109 |
|
|
2021
Q2 | $890K | Buy |
+6,571
| New | +$890K | 0.24% | 109 |
|